Start with the prescription and pharmacy
Federal law prohibits supplying prescription medicine without a valid prescription, as of September 26, 2026.
Ask which licensed person would assess you and which pharmacy would supply the product.
Some compounded semaglutide and tirzepatide labels have carried false pharmacy details, according to findings by the Food and Drug Administration (FDA).
Compounded means made or changed to meet patient needs.
The medicine name and the pharmacy name are both worth checking.
Open the sources for this answer
Open the answer behind a reassuring phrase
Does “FDA registered” mean the medicine was approved?
No. A registration entry does not show FDA approval for a facility or its medicine, as of September 26, 2026.
Does a prescription settle the approval question?
No. A prescription for a compounded medicine does not give it FDA approval, as checked on September 26, 2026.
Does a government drug code prove approval?
No. The FDA says a National Drug Code is not evidence of approval, as checked on September 26, 2026.
The government drug directory uses an identifying code called a National Drug Code.
Open the sources for this answer
Treat “research use” as a question about the product
The FDA’s advice, as of September 26, 2026, is to avoid research-labelled weight-loss products sold directly to people for use.
Their quality is not known, and using them may harm health.
Ask for a clear explanation of the exact product and its status. If the answer keeps changing, pause the decision.
Open the sources for this answer
Keep price in its place
A very low price is one warning sign in the FDA’s pharmacy checklist, not proof by itself that an offer is wrong.
Read it alongside the prescription, licence and pharmacy checks.
Return to the care-check questions